DGAP-Adhoc

LifeWatch achieves volume growth of 13.1% in the first half of 2014 - Seite 2

financial reporting systems.

Vital Signs Patch on track for launch in 2015
LifeWatch signed 19 new or amended agreements for NiteWatch Home Sleep Test
services and Ambulatory Cardiac Telemetry (ACT) services during the first
half of 2014. We further expect to launch the Vital Signs Patch (VSP) in
the first half of 2015, following marketing clearance from the FDA. This
potentially game changing technology is an easy to use sensor worn on a
patient's upper chest. Once activated, the system provides automation and
alerts of key vital signs via continuous wireless monitoring.

Outlook
LifeWatch expects to exceed its goal of USD 100 million in revenues in
2014, with an improvement in EBIT and EBITDA. We are confident of growing
revenues by strengthening our market share in existing markets as well as
globalizing our service offerings.
Dr Stephan Rietiker commented: "I strongly believe in our company's people,
technology and service offering and I am working, together with my team, to
bring the company to the next level. I also firmly believe that this year
of transition will set the stage for the future and I am excited about the
prospects for the company."

Key figures (unaudited, USD millions):

H1 2014 H1 2014 H1 2013
adjusted

Revenues 48.12 48.12 43.68
Gross Profit 26.93 25.09 25.92
As % of revenues 56.0% 52.1% 59.3%
EBITDA / (LBITDA) 1.45 (1.52) 4.32
As % of revenues 3.0% NA 9.9%
EBIT / (LBIT) (1.16) (4.13) 2.71
As % of revenues NA NA 6.2%
Net income (loss) (1.75) (4.72) 8.88
Earnings per share (basic) (0.36) 0.68
Total fixed assets, net 13.02 7.76
Total Assets 68.54 69.28
Total equity 34.82 44.12
As % of assets 51% 64%
Net Cash Flow (3.92) 4.97
Employees 561 535

Adjustments to H1 2014 figures USD millions
LifeWatch V Healthphone inventory write-off 1.19